Have you experienced a broken bone or fracture while using the osteoporosis drug Didronel? If so, you may be entitled to compensation. As reported by the U.S. Food & Drug Administration (FDA), bisphosphonate medications like Didronel have been linked to bone disease and atypical femur fractures.
Didronel Update 6/28/12: In a new web guide published by the FDA, the administration lays out new guidance for the use of bisphosphonates, tentatively recommending a three to five year time limit for the drugs, at least until more conclusive data becomes available. The five-year time limit was originally suggested in a September 2011 report issued by the FDA, which concluded that there appears to be no tangible benefit to extending bisphosphonate regimens beyond five years. Click here to learn more.
Didronel Bone Fracture Update 5/24/12: In a study published this week by the Archives of Internal Medicine, Swiss researchers reached conclusions similar to those reached earlier this month by the U.S. Food & Drug Administration (FDA) – that taking osteoporosis drugs from the bisphosphonate class can increase the risk of atypical bone fractures. Taken cumulatively, the results of the study seem to suggest that the risk of fractures increased over time while the benefits of the drugs decreased. Click here to learn more.
Free Didronel Case Evaluation: If you or someone you care about has suffered a femur fracture or broken bones after taking Didronel, you should contact our law firm immediately. You may be entitled to compensation by filing a lawsuit and we can help.
What’s the problem?
Didronel (etidronate) is a prescription osteoporosis medication designed to alter the cycle of bone formation and breakdown in the body. It belongs to a group of drugs known as bisphosphonates that work by reducing the risk of osteoporotic fracture in patients who have had previous fractures. However, bisphosphonates like Didronel do not reduce fracture risk in those with osteoporosis who have not previously had a fracture. As well, a high number patients using bisphosphonate drugs similar to Didronel have developed severe bone loss, atypical femur fractures and other extremely serious side effects.
Didronel Side Effects
There are a variety of side effects associated with Didronel. Our firm is pursing the following types of severe side effects:
- Osteonecrosis of the Jaw (Dead Jaw)
- Atypical femur fractures
- Swelling or infection of the gums
- Loosening of the teeth
- Poor healing of the gums
- Numbness or a feeling of heaviness in the jaw
- Exposed bone
- Hip Fractures
Bisphosphonate Osteoporosis Drugs
Bisphosphonate medications used to treat the effects of osteoporosis include the following brands:
FDA Warning on Bisphosphonates
On October 13, 2010, the FDA announced a labeling change to the above bisphosphonate medications to reflect the risk of atypical thigh bone fractures in patients taking the drugs. While it is not clear whether bisphosphonates are the definite cause, these types of injuries have been predominantly reported in individuals taking bisphosphonates. In the announcement, the FDA highlighted the fact that the optimal duration of bisphosphonate use is uncertain, and that bone fractures may be related to use of these medications for longer than five years.
If you are taking Didronel
Do not take Didronel if you have a condition called osteomalacia (softening of the bones), or any difficulties with the movement of muscles in your esophagus. If you have experienced a bone fracture, stomach ulcer or kidney disease, you may need to undergo special tests to determine whether Didronel is safe for you. Other preexisting conditions to inform your doctor about include blood clotting disorders, anemia and pre-existing dental problems.
Do I have a Didronel Lawsuit?
The Product Liability & Defective Drug Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Didronel lawsuits. We are handling individual litigation nationwide and currently accepting new bone fracture injury cases in all 50 states.